Chondrial Therapeutics
Latest round
- Series A
Last raised
- Feb 2017
Total raised
- $23M
Investors
- 1
About Chondrial Therapeutics
Chondrial Therapeutics, Inc.Founded in 2013 in the United States, Chondrial Therapeutics, Inc. is engaged in creating novel treatments for rare genetic disorders. The company has not undergone any notable business pivots or changes.Chondrial Therapeutics specializes in developing innovative treatments for rare diseases utilizing a proprietary intracellular delivery platform that facilitates the direct delivery of proteins and therapeutic molecules into cells. Its lead candidate, nomlabofusp (previously CTI-1601), aims to deliver human frataxin to patients with Friedreich’s ataxia, a rare genetic disorder that leads to progressive neurological decline. Currently in Phase 2 clinical trials, nomlabofusp seeks to improve patient quality of life.Chondrial Therapeutics' revenue model is structured around the development and potential commercialization of its lead product, nomlabofusp, alongside future offerings from its delivery platform. The company may engage in strategic partnerships with various stakeholders, including pharmaceutical distributors and healthcare providers, to enhance its market presence. Revenue generation is expected to stem from licensing agreements that grant production or commercialization rights to other firms, as well as direct sales to healthcare facilities upon obtaining regulatory approval.Chondrial Therapeutics is focused on advancing its lead product, nomlabofusp, through its ongoing Phase 2 clinical trials. The overall strategy emphasizes building partnerships within the healthcare ecosystem to facilitate the adoption of their innovative therapies.
Who invested in Chondrial Therapeutics
1 investor across 1 round
See all investors in Chondrial Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 1, 2017
Amount
$23M
Investors
Questions about Chondrial Therapeutics
Who invested in Chondrial Therapeutics?
Chondrial Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chondrial Therapeutics raised?
Chondrial Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Chondrial Therapeutics last raise money?
Chondrial Therapeutics's most recent round on record is a Series A, in Feb 2017.
What does Chondrial Therapeutics do?
Chondrial Therapeutics is a pharmaceuticals company.
Where is Chondrial Therapeutics headquartered?
Chondrial Therapeutics is headquartered in US.
Which VCs invest in companies like Chondrial Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Chondrial Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Chondrial Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.